N. Vidnovic

470 total citations
7 papers, 381 citations indexed

About

N. Vidnovic is a scholar working on Pathology and Forensic Medicine, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, N. Vidnovic has authored 7 papers receiving a total of 381 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pathology and Forensic Medicine, 4 papers in Oncology and 3 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in N. Vidnovic's work include Lymphoma Diagnosis and Treatment (4 papers), Cancer-related Molecular Pathways (3 papers) and Cancer Research and Treatments (3 papers). N. Vidnovic is often cited by papers focused on Lymphoma Diagnosis and Treatment (4 papers), Cancer-related Molecular Pathways (3 papers) and Cancer Research and Treatments (3 papers). N. Vidnovic collaborates with scholars based in United States and Malaysia. N. Vidnovic's co-authors include Leif W. Ellisen, Dennis C. Sgroi, M. Phillip DeYoung, Chee‐Onn Leong, Lee Yong Lim, Norbert Avril, Kenneth A. Foon, Judith M. Joyce, Paul E. Goss and Samuel A. Jacobs and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and Blood.

In The Last Decade

N. Vidnovic

7 papers receiving 376 citations

Peers

N. Vidnovic

ONCOL

MB

CR

BIOTE

PRM

Ewoud N. Speksnijder Netherlands

Jana Wendt Germany

E Schulze Schleithoff Italy

Laura Ghisolfi United States

Jude Alsarraj United States

Sébastien L. Floor Belgium

Jessica Ekedahl Sweden

Gabriela Koifman Israel

Bettina Miller United States

Ewoud N. Speksnijder Netherlands

N. Vidnovic

223 ×0.9

ONCOL

288 ×1.2

MB

125 ×1.1

CR

22 ×0.5

BIOTE

36 ×0.9

PRM

Citations per year, relative to N. Vidnovic N. Vidnovic (= 1×) peers Ewoud N. Speksnijder

Countries citing papers authored by N. Vidnovic

Since Specialization

Citations

This map shows the geographic impact of N. Vidnovic's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N. Vidnovic with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N. Vidnovic more than expected).

Fields of papers citing papers by N. Vidnovic

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by N. Vidnovic. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N. Vidnovic. The network helps show where N. Vidnovic may publish in the future.

Co-authorship network of co-authors of N. Vidnovic

This figure shows the co-authorship network connecting the top 25 collaborators of N. Vidnovic. A scholar is included among the top collaborators of N. Vidnovic based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with N. Vidnovic. N. Vidnovic is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Lim, Lee Yong, et al.. (2009). Mutant p53 mediates survival of breast cancer cells. British Journal of Cancer. 101(9). 1606–1612. 147 indexed citations

2.

Jacobs, Samuel A., Anthony M. Harrison, Steven H. Swerdlow, et al.. (2008). Radioisotopic Localization of 90Yttrium–Ibritumomab Tiuxetan in Patients with CD20+ Non-Hodgkin’s Lymphoma. Molecular Imaging and Biology. 11(1). 39–45. 9 indexed citations

3.

Leong, Chee‐Onn, N. Vidnovic, M. Phillip DeYoung, Dennis C. Sgroi, & Leif W. Ellisen. (2007). The p63/p73 network mediates chemosensitivity to cisplatin in a biologically defined subset of primary breast cancers. Journal of Clinical Investigation. 117(5). 1370–1380. 217 indexed citations

4.

Isakoff, Steven J., N. Vidnovic, M. Phillip DeYoung, et al.. (2007). p63/p73 expression mediates cisplatin sensitivity in a subset of triple-negative primary breast cancer: Implications for a new clinical trial. Journal of Clinical Oncology. 25(18_suppl). 10522–10522. 5 indexed citations

5.

Jacobs, Samuel A., Norbert Avril, N. Vidnovic, et al.. (2005). Localization of yttrium 90 ibritumomab tiuxetan (⁹⁰Y IT) in patients with CD20 + non-Hodgkin’s lymphoma (NHL). Journal of Clinical Oncology. 23(16_suppl). 2547–2547. 1 indexed citations

6.

Jacobs, Samuel A., Anthony M. Harrison, Steven H. Swerdlow, et al.. (2004). Cellular Localization Pattern of Yttrium 90 (90Y) Ibritumomab Tiuxetan (Zevalin®) in a Patient with Low-Grade Non-Hodgkin’s Lymphoma (NHL).. Blood. 104(11). 4569–4569. 1 indexed citations

7.

Jacobs, Samuel A., Barry McCook, Frank Torok, et al.. (2004). Evaluation of Yttrium 90 (90Y) Ibritumomab Tiuxetan (Zevalin®) in Patients with Non-Hodgkin’s Lymphoma (NHL) Having Previously Received Autologous Stem Cell Transplant (ASCT).. Blood. 104(11). 5238–5238. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact